Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Classement en actions #27020
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Prix de l'action
$0.16240909
Dernière synchronisation: 2025-03-04
Capitalisation boursière
$35.68M
Changement (1 jour)
0.27%
Changement (1 an)
0.00%
Pays
CN
Échange Dali Pharmaceuticalco.,Ltd (603963)

Catégorie

Ratio P/B pour Dali Pharmaceuticalco.,Ltd (603963)
Ratio P/B au August 2026 TTM : 0.69
Selon les derniers rapports financiers et le cours de l'action de Dali Pharmaceuticalco.,Ltd, le ratio cours/valeur comptable actuel (TTM) est 0.69. À la fin de 2022, le ratio P/B était de 7.15.
Historique du ratio P/B pour Dali Pharmaceuticalco.,Ltd de 2012 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 0.69 -90.07%
2023 6.94 -3.00%
2022 7.15 54.26%
2021 4.64 27.40%
2020 3.64 -10.88%
2019 4.08 16.91%
2018 3.49 -22.46%
2017 4.51 -29.63%
2016 6.40 36.88%
2015 4.68 39.56%
2014 3.35 -4.78%
2013 3.52 -35.78%
2012 5.48 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes